InBioGen Co Ltd (101140) — Capital Reinvestment Ratio

Latest as of December 2024: 0.04x

InBioGen Co Ltd (101140) has a Capital Reinvestment Ratio of 0.04x as of December 2024, meaning it reinvests 0% of its operating cash flow (₩1.36 Billion) in capital expenditures (₩60.00 Million). Check 101140 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

₩1.36 Billion

KRW

Capital Expenditures

₩60.00 Million

KRW

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for InBioGen Co Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for InBioGen Co Ltd from None to None. See how much free cash does InBioGen Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow